Format

Send to

Choose Destination
Am J Transplant. 2019 May 6. doi: 10.1111/ajt.15418. [Epub ahead of print]

Macrosteatosis is a huge problem in liver transplantation - however, not the only one we face.

Author information

1
Department of Surgery, Campus Charité Mitte and Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Berlin, Germany.
2
German Organ Transplantation Foundation (Deutsche Stiftung Organtransplantation, DSO), Frankfurt, Germany.
3
BIH Charité Clinician Scientist Program, Berlin Institute of Health (BIH), Berlin, Germany.

Abstract

We read, with great interest, the work from Croome et al. on "The impact of post-reperfusion syndrome using livers with significant macrosteatosis" in which the authors demonstrate in a propensity score matched cohort, that steatosis hepatis is associated with post-reperfusion syndrome (PRS), early allograft dysfunction (EAD) and renal dysfunction, while not directly affecting graft or patient survival. This article is protected by copyright. All rights reserved.

PMID:
31062467
DOI:
10.1111/ajt.15418

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center